Valvular Disease
10
0
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
Impact of Cardiopulmonary Bypass Time on Gastrointestinal Complications
Enhancing Cardiac Rehabilitation Through Behavioral Nudges
NOrthwestern Tempus AI-enaBLed Electrocardiography (NOTABLE) Trial
Role of Statins In Slowing Rheumatic Heart Disease (RHD) Progression
Epidemiology and Long-term Outcome of Patients With VHD
Focused Cardiac Ultrasound
T1-mapping by Cardiovascular Magnetic Resonance Imaging to Assess Non-Alcoholic Fatty Liver Disease
Evaluation of the Brain Natriuretic Peptide as a Predictor of Morbidity and Mortality in Cardiac Surgery
Filling Pressures of the Left Ventricle in Patients With Significant Aortic Stenosis
The Scanner in the Coronary Evaluation